SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction
Authors:
- Lara MarroneLMLara Marrone
- Paolo M MarchiPMPaolo M Marchi
- Christopher P WebsterCWChristopher P Webster
- Raffaele MarroccellaRMRaffaele Marroccella
- Ian ColdicottICIan Coldicott
- Steven ReynoldsSRSteven Reynolds
- João Alves-CruzeiroJAJoão Alves-Cruzeiro
- Zih-Liang YangZYZih-Liang Yang
- Adrian HigginbottomAHAdrian Higginbottom
- Mukhran KhundadzeMKMukhran Khundadze
- Christian A HübnerCHChristian A Hübner
Open Access
- 21 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 31 (16) , 2693-2710
Abstract
Hereditary spastic paraplegia type 15 (HSP15) is a neurodegenerative condition caused by the inability to produce SPG15 protein, which leads to lysosomal swelling. However, the link between lysosomal aberrations and neuronal death is poorly explored. To uncover the functional consequences of lysosomal aberrations in disease pathogenesis, we analyze human dermal fibroblasts from HSP15 patients as well as primary cortical neurons derived from an SPG15 knockout (KO) mouse model. We find that SPG15 protein loss induces defective anterograde transport, impaired neurite outgrowth, axonal swelling and reduced autophagic flux in association with the onset of lysosomal abnormalities. Additionally, we observe lipid accumulation within the lysosomal compartment, suggesting that distortions in cellular lipid homeostasis are intertwined with lysosomal alterations. We further demonstrate that SPG15 KO neurons exhibit synaptic dysfunction, accompanied by augmented vulnerability to glutamate-induced excitotoxicity. Overall, our study establishes an intimate link between lysosomal aberrations, lipid metabolism and electrophysiological impairments, suggesting that lysosomal defects are at the core of multiple neurodegenerative disease processes in HSP15.Keywords
Funding Information
- SITraN career track fellowship
- DFG (01GM1905, HU 800/13-2)
- MRC (MR/V030140/1, MR/G1001492)
- ARUK, IMI Award (945473)
- CureAP4, JPND (MR/V000470/1)
- European Research Council (294745)
- University of Sheffield
- British Neuropathological Society
- Maddi Foundation and Spastic Paraplegia Foundation
This publication has 58 references indexed in Scilit:
- Influence of GluN2 subunit identity on NMDA receptor functionNeuropharmacology, 2013
- Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15Molecular Biology of the Cell, 2013
- Synaptic Vesicle EndocytosisCold Spring Harbor Perspectives in Biology, 2012
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosumNeurology, 2009
- Autophagy regulates lipid metabolismNature, 2009
- Identification of the SPG15 Gene, Encoding Spastizin, as a Frequent Cause of Complicated Autosomal-Recessive Spastic Paraplegia, Including Kjellin SyndromeThe American Journal of Human Genetics, 2008
- Cellular cholesterol trafficking and compartmentalizationNature Reviews Molecular Cell Biology, 2008
- Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron DegenerationThe American Journal of Human Genetics, 2008
- The extent of axonal loss in the long tracts in hereditary spastic paraplegiaNeuropathology and Applied Neurobiology, 2004